DNA Sequencing

DNA Sequencing


Global DNA Sequencing Market to Reach US$17.1 Billion by 2030

The global market for DNA Sequencing estimated at US$7.8 Billion in the year 2023, is expected to reach US$17.1 Billion by 2030, growing at a CAGR of 11.8% over the analysis period 2023-2030. DNA Sequencing Consumables, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$7.5 Billion by the end of the analysis period. Growth in the DNA Sequencing Instruments segment is estimated at 10.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.1 Billion While China is Forecast to Grow at 15.9% CAGR

The DNA Sequencing market in the U.S. is estimated at US$3.1 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 15.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.8% and 9.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.0% CAGR.

Global DNA Sequencing Market - Key Trends & Drivers Summarized

What Is DNA Sequencing and Why Is It Transformative?

DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. It includes any method or technology that is used to determine the order of the four bases—adenine, guanine, cytosine, and thymine—in a strand of DNA. The ability to sequence DNA quickly and affordably has become a pivotal factor in biological research, enabling scientists to observe the genetic blueprint that guides the development, functioning, and reproduction of living organisms and viruses. Over the past few decades, advancements in DNA sequencing technologies have revolutionized the field of genomics, leading to profound insights into the genetic bases of many diseases, the evolution of species, and identification of genetic variability among populations.

How Has Technology Advanced in DNA Sequencing?

Technological advancements in DNA sequencing have largely followed the trajectory from first-generation sequencing, which includes methods like Sanger sequencing, to next-generation sequencing (NGS), which allows for sequencing of millions of small fragments of DNA in parallel, significantly reducing the time and cost associated with DNA sequencing. NGS platforms have undergone rapid enhancements that have increased accuracy, speed, and affordability, making large-scale projects like whole-genome sequencing and personalized genomics feasible for more researchers and clinicians. Additionally, the development of third-generation sequencing technologies, which include single-molecule real-time sequencing techniques, promises to further revolutionize the field by offering even faster and more accurate sequencing capabilities without the need for amplification of DNA samples.

What Are the Major Applications of DNA Sequencing?

The applications of DNA sequencing are extensive and varied across multiple fields. In healthcare, it is used for diagnosing genetic disorders, identifying mutations that may lead to cancer, and guiding treatment decisions based on an individual’s genetic makeup. In agriculture, DNA sequencing assists in creating high-yield, pest-resistant crops by enabling precise alterations to the genetic structure of plants. Furthermore, in forensic science, sequencing can identify individuals with high accuracy from minute samples of DNA. Environmental scientists use DNA sequencing to study biodiversity, understand population genetics, and track the effects of environmental changes on genetic material in ecosystems. Each application demonstrates the significant impact of DNA sequencing technologies in advancing our understanding and management of complex biological systems.

Growth in the DNA Sequencing Market Is Driven by Several Factors

The growth in the DNA sequencing market is driven by several factors, including rapid technological advancements, decreasing costs, and expanding applications across various fields. The increasing adoption of precision medicine, which relies heavily on genetic information to tailor individual treatment plans, is a major growth driver. Furthermore, the global rise in genetic research activities, bolstered by government and private funding, contributes significantly to the demand for advanced sequencing solutions. Consumer behavior also influences market growth, as there is a growing interest in personalized health assessments and ancestry services, which utilize DNA sequencing. Additionally, the COVID-19 pandemic highlighted the importance of rapid sequencing technologies in identifying and tracking virus mutations, underscoring the critical role of DNA sequencing in responding to global health challenges. These factors collectively fuel the ongoing expansion and innovation within the DNA sequencing market, making it one of the most dynamic areas in genomics research.

Select Competitors (Total 76 Featured) -
  • Eppendorf AG
  • Adaptive Biotechnologies Corporation
  • Cofactor Genomics, Inc.
  • Annoroad Gene Technology
  • ADS Biotec, Inc.
  • BGI Genomics Co Ltd.
  • DayTwo
  • Dynasty Gene
  • Clevergene
  • Ares Genetics GmbH
  • DDL Diagnostic Laboratory
  • DelphiTest GmbH
  • DNA link
  • ARL Bio Pharma, Inc.
  • Celgene Corporation
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
DNA Sequencing - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
An Introduction
A Brief History on Evolution of DNA Sequencing Technology
Different Types of Sequencing Approaches
Shotgun Sequencing
High-Throughput Approach
Long-Read Sequencing Approaches
Single Molecule Real Time (SMRT) Sequencing
Nanopore DNA Sequencing
Short-Read Sequencing Approaches
Massively Parallel Signature Sequencing (MPSS)
Massively Parallel Signature Sequencing (MPSS)
Polony Sequencing
454 Pyrosequencing
Illumina (Solexa) Sequencing
Combinatorial Probe Anchor Synthesis (cPAS)
SOLiD sequencing
Ion Torrent Semiconductor Sequencing
DNA Nanoball Sequencing
Heliscope Single Molecule Sequencing
Microfluidic Systems
A Prelude to DNA Sequencing
Major Applications
DNA Sequencing Application
Global Market Prospects and Outlook
DNA Sequencing Market Set for a Rapid Growth
Regional Market Perspective
North America Leads the Global Market
Competition
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Next Generation Sequencing Drives the Market Growth
Increasing R&D Activities in NGS
Illumina, the Dominant Force in the Global NGS Market
Growing Adoption of Sequencing Services in Clinical Workflows Propels Market Growth
Increasing Use in Drug Discovery Drives Market Growth
Increasing Emphasis on Personalized Medicine Drives Market Growth
Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
Rising Incidence of Cancer to Drive Market Growth
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
Number of New Cancer Cases and Deaths (in Million) by Region for 2018
DNA Sequencing and Cancer Care
Technological Advancements in NGFS Aids Market Expansion
The First Mobile Genome Sequence Analyzer in the World
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Reproductive Health by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Clinical Investigation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Clinical Investigation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Clinical Investigation by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Forensics & Agrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Forensics & Agrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Forensics & Agrigenomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for HLA Typing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for HLA Typing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for HLA Typing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Consumer Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 29: World Historic Review for Consumer Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 30: World 16-Year Perspective for Consumer Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 31: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 32: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 33: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 34: World Recent Past, Current & Future Analysis for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 35: World Historic Review for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 36: World 16-Year Perspective for Academic Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 37: World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 38: World Historic Review for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 39: World 16-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 40: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 41: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 42: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 43: World Recent Past, Current & Future Analysis for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 44: World Historic Review for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 45: World 16-Year Perspective for Pharma & Biotech by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 46: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 47: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 48: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 49: World DNA Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 50: USA Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: USA Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: USA 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
TABLE 53: USA Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: USA Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: USA 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
TABLE 56: USA Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: USA Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: USA 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 59: Canada Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Canada Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Canada 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
TABLE 62: Canada Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Canada Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Canada 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
TABLE 65: Canada Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Canada Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Canada 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 68: Japan Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Japan Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Japan 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
TABLE 71: Japan Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Japan Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Japan 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
TABLE 74: Japan Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Japan Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: Japan 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 77: China Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: China Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: China 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
TABLE 80: China Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: China Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: China 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
TABLE 83: China Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: China Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: China 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 86: Europe Recent Past, Current & Future Analysis for DNA Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 87: Europe Historic Review for DNA Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Europe 16-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 89: Europe Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Europe Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Europe 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
TABLE 92: Europe Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Europe Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Europe 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
TABLE 95: Europe Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Europe Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Europe 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 98: France Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: France Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: France 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
TABLE 101: France Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: France Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: France 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
TABLE 104: France Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: France Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: France 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 107: Germany Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Germany Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Germany 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
TABLE 110: Germany Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: Germany Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: Germany 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
TABLE 113: Germany Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: Germany Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: Germany 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 116: Italy Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: Italy Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: Italy 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
TABLE 119: Italy Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: Italy Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: Italy 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
TABLE 122: Italy Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: Italy Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: Italy 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 125: UK Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: UK Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: UK 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
TABLE 128: UK Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: UK Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: UK 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
TABLE 131: UK Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 132: UK Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: UK 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Rest of Europe Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Rest of Europe 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Rest of Europe Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Rest of Europe 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Rest of Europe Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Rest of Europe 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Asia-Pacific Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Asia-Pacific 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 147: Asia-Pacific Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Asia-Pacific 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Asia-Pacific Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Asia-Pacific 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 152: Rest of World Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Rest of World Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Rest of World 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
TABLE 155: Rest of World Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 156: Rest of World Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: Rest of World 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
TABLE 158: Rest of World Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: Rest of World Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: Rest of World 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings